The Empire Plan Covers Shingrix Vaccine for Prevention of Shingles

The Centers for Disease Control (CDC) recently approved Shingrix as a recommended vaccine for (Shingles) herpes zoster.  The Shingrix vaccine has also been recommended by the Advisory Committee on Immunization Practices (ACIP) for the prevention of herpes zoster and related complications for those age 50 and older and is therefore required to be covered as a preventive service for this age group.

 

Effective April 1, 2018, the Shingrix vaccine will be covered by both the Empire Plan Medical/Surgical Program and by the Prescription Drug Program through the CVS Caremark Vaccine Network. There will be no enrollee cost share for the Shingrix vaccine for enrollees age 50 and older when administered by an in-network provider.  Any Shingrix vaccine that was administered prior to April 1, 2018 will be a covered service but will have enrollee cost share applied.

 

Please be aware that the Shingrix vaccine requires two shots to be administered and both Shingrix shots will be covered as described above.